Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2004 Oct;8(5):325-6.
doi: 10.1186/cc2949. Epub 2004 Sep 6.

Erythropoietin in the critically ill - is it more than just blood?

Howard L Corwin  1
Affiliations
Comment

Erythropoietin in the critically ill - is it more than just blood?

Howard L Corwin. Crit Care. 2004 Oct.

Abstract

Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.

PubMed Disclaimer

Comment on

References

    1. Henry DH, Bowers P, Romano MT, Provenzano R. Epoetin Alfa: clinical evolution of a pleiotropic cytokine. Arch Intern Med. 2004;164:262–276. doi: 10.1001/archinte.164.3.262. - DOI - PubMed
    1. Erbayraktar S, Yilmaz O, Gokmen N, Brines M. Erythropoietin is a multifactorial tissue-protective cytokine. Curr Hematol Rep. 2003;2:465–470. - PubMed
    1. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, et al. The use of subcutaneous erythropoietin intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalization. J Am Coll Cardiol. 2000;35:1737–1744. doi: 10.1016/S0735-1097(00)00613-6. - DOI - PubMed
    1. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med. 2002;8:495–505. - PMC - PubMed
    1. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Erythropoietin crosses the blood brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA. 2000;97:10526–10531. doi: 10.1073/pnas.97.19.10526. - DOI - PMC - PubMed

Publication types